Trial Profile
A Randomized Study Combining Etanercept and Short Courses of Narrow-Band UVB in Patients With Psoriasis Vulgaris.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 05 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 05 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2009 New trial record.